Free Trial
NYSE:AGL

Agilon Health Q3 2026 Earnings Date & Estimates

Agilon Health logo
$83.05 -1.67 (-1.98%)
As of 01:54 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Agilon Health is scheduled to report Q3 2026 earnings on Wednesday, November 4, 2026, after market closes. The conference call is scheduled for 4:30 PM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call
4:30 PM ET

What Analysts Expect from Agilon Health in Q3 2026

Agilon Health is expected to post earnings of -$1.23 per share on revenue of $1.46 billion. In the same quarter a year earlier Agilon Health reported -$6.75 per share on revenue of $1.44 billion. Agilon Health last reported on August 5, 2026, posting $1.04 per share and beating the $0.1440 consensus estimate. Agilon Health has beaten the consensus EPS estimate in 3 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$1.23
Expected Revenue
$1.46 billion
Prior-Year EPS
-$6.75
Prior-Year Revenue
$1.44 billion
Expected Revenue Growth
+1.8%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$1.04 (Beat by +$0.8960)
Last Quarter Revenue
$1.49 billion
EPS Beat Rate
3 of last 8 quarters

Agilon Health Q3 2026 Earnings FAQ

Agilon Health (NYSE:AGL) has confirmed it will report Q3 2026 earnings on Wednesday, November 4, 2026, after market closes.

Agilon Health's Q3 2026 earnings conference call is scheduled for Wednesday, November 4, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Agilon Health to post earnings of -$1.23 per share for Q3 2026.

The consensus revenue estimate for Agilon Health is $1.46 billion for Q3 2026.

Agilon Health Earnings Headlines

Why Did agilon health (AGL) Move Today?
Bernstein Sticks to Its Buy Rating for Agilon Health (AGL)
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in could be a costly mistake. He calls it among the most overhyped, overvalued large-cap offerings ever pushed onto everyday investors. Tilson believes a rare economic event is approaching - one with serious consequences for your portfolio this summer. He has prepared a free analysis outlining what he sees and the specific steps he recommends taking now.tc pixel
See More Agilon Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Agilon Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Agilon Health and other key companies, straight to your email.

About Agilon Health

Agilon Health (NYSE:AGL) is a healthcare company that helps primary care physicians transition from traditional fee-for-service medicine to value-based care. The company primarily works with independent physician practices that serve older adults, particularly Medicare Advantage members, with the goal of improving care coordination, patient outcomes and the overall healthcare experience.

Agilon provides a technology and services platform designed to support population health management. Its offerings include data analytics, clinical and administrative workflows, practice management support, care coordination resources and assistance with payer contracting. Through these capabilities, the company helps physicians manage the health needs of their patient populations while taking greater responsibility for quality and cost outcomes.

Founded in 2016, Agilon Health partners with physician organizations in local communities across the United States. Its model is built around long-term relationships with primary care providers, payers and other healthcare participants, with services tailored to the needs of each market. The company is led by President and Chief Executive Officer Steve Sell.

View Agilon Health Profile